Mechanisms of ranibizumab as an anti- scarring agent in trabeculectomy / Siti Munirah Md Noh
Trabeculectomy is the gold standard procedure performed in glaucoma when topical medication and laser intervention fail to maintain the ideal intraocular pressure (IOP) of patient’s eye. However, excessive accumulation of extracellular matrix components (ECM) mediated by Tenon’s fibroblast (HTF) lea...
Saved in:
Main Author: | Md Noh, Siti Munirah |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | https://ir.uitm.edu.my/id/eprint/62204/1/62204.pdf https://ir.uitm.edu.my/id/eprint/62204/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of ranibizumab as an anti-scarring agent in trabeculectomy / Siti Munirah Md Noh
by: Md Noh, Siti Munirah
Published: (2018) -
Ranibizumab inhibits human tenon's fibroblast proliferation via p21 dependent p53 mechanisms
by: Md Noh, Siti Munirah, et al.
Published: (2021) -
An animal experimental study on the intravitreal injection of ranibizumab as an adjunctice treatment in retinoblastoma
by: Abd Aziz, Nor Azimah
Published: (2015) -
A pilot study of intralesional ranibizumab on pterygium vascularity, size and recurrence rate
by: Chi, Ho Hao
Published: (2015) -
Long-Term intraocular pressure changes in patients with neovascular age-related macular degeneration treated with Ranibizumab
by: Menke, Marcel N., et al.
Published: (2013)